1223498-50-7

Basic information

• Product Name: 4-{[(1R,2R)-2-(benzyloxy)-1-methylpropyl]oxy}-2-chloro-5-(trifluoromethyl)pyrimidine
• Synonyms: 4-{[(1R,2R)-2-(benzyloxy)-1-methylpropyl]oxy}-2-chloro-5-(trifluoromethyl)pyrimidine
• CAS NO: 1223498-50-7
• Molecular Weight: 360.763
• Mol File: 1223498-50-7.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 453.2±45.0 °C(Predicted)
• Density: 1.292±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 4-{[(1R,2R)-2-(benzyloxy)-1-methylpropyl]oxy}-2-chloro-5-(trifluoromethyl)pyrimidine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-{[(1R,2R)-2-(benzyloxy)-1-methylpropyl]oxy}-2-chloro-5-(trifluoromethyl)pyrimidine(1223498-50-7)
• EPA Substance Registry System: 4-{[(1R,2R)-2-(benzyloxy)-1-methylpropyl]oxy}-2-chloro-5-(trifluoromethyl)pyrimidine(1223498-50-7)

Safety Data

• Hazardous Substances Data: 1223498-50-7(Hazardous Substances Data)

Upstream product

• 1125-88-8 benzaldehyde dimethyl acetal 
• 124338-52-9 (2R,3R)-3-(phenylmethoxy)-2-butanol 
• 3932-97-6 2,4-dichloro-5-trifluoromethylpyrimidine 
• 1223498-47-2 4-{[(1R,2R)-2-(benzyloxy)-1-methylpropyl]oxy}-2-chloro-5-iodopyrimidine 
• 81290-20-2 (trifluoromethyl)trimethylsilane 
• 100-39-0 benzyl bromide 

Downstream Products

• 1224162-14-4 4-{[(2R,3R)-3-(benzyloxy)butan-2-yl]oxy}-N-[4-(methylsulfonyl)phenyl]-5-(trifluoromethyl)pyrimidin-2-amine 
• 1224162-19-9 2-{4-[4-((1R,2R)-2-Benzyloxy-1-methylpropoxy)-5-trifluoromethylpyrimidin-2-ylamino]benzene-sulphonyl}ethanol 
• 1224162-18-8 [4-((1R,2R)-2-benzyloxy-1-methylpropoxy)-5-trifluoromethylpyrimidin-2-yl][4-(propane-2-sulphonyl)phenyl]amine 
• 1224162-16-6 [4-((1R,2R)-2-Benzyloxy-1-methylpropoxy)-5-trifluoro-methylpyrimidin-2-yl][4-(difluoromethane-sulphonyl)phenyl]amine 
• 1224162-02-0 (2R,3R)-3-[2-(4-Cyclopropanesulphonylphenylamino)-5-trifluoromethylpyrimidin-4-yloxy]butan-2-ol 
• 1224162-13-3 [4-((1R,2R)-2-Benzyloxy-1-methylpropoxy)-5-trifluoromethylpyrimidin-2-yl](4-cyclopropane-sulphonylphenyl)amine 
• 1224162-03-1 (2R,3R)-3-{[2-{[4-(methylsulfonyl)phenyl]amino}-5-(trifluoromethyl)pyrimidin-4-yl]oxy}butan-2-ol 
• 1224162-07-5 (2R,3R)-3-{2-[4-(Difluoromethanesulphonyl)phenylamino]-5-trifluoromethylpyrimidin-4-yloxy}butan-2-ol 
• 1224162-10-0 (2R,3R)-3-{2-[4-(Propane-2-sulphonyl)phenylamino]-5-trifluoromethylpyrimidin-4-yloxy}butan-2-ol 
• 1224162-17-7 [4-((1R,2R)-2-benzyloxy-1-methylpropoxy)-5-trifluoromethylpyrimidin-2-yl]-(4-cyclopentanesulphonylphenyl)amine 
• 1224162-15-5 (4-benzenesulphonylphenyl)[4-((1R,2R)-2-benzyloxy-1-methylpropoxy)-5-trifluoromethylpyrimidin-2-yl]amine 
• 1224162-06-4 (2R,3R)-3-[2-(4-benzenesulphonylphenylamino)-5-trifluoromethylpyrimidin-4-yloxy]butan-2-ol 
• 1224162-08-6 (2R,3R)-3-[2-(4-cyclopentanesulphonylphenylamino)-5-trifluoromethylpyrimidin-4-yloxy]butan-2-ol 
• 1365543-64-1 N-[(4-{[4-{[(2R,3R)-3-(benzyloxy)butan-2-yl]oxy}-5-(trifluoromethyl)pyrimidin-2-yl]amino}phenyl)(cyclopropyl)oxido-lambda⁶-sulphanylidene]-2,2,2-trifluoroacetamide benzenesulphonic acid salt 

Relevant articles and documents

The lab oddity prevails: Discovery of Pan-CDK inhibitor (R)-S-Cyclopropyl-S-(4-{[4-{[(1R,2R)-2-hydroxy-1-methylpropyl]oxy}-5-(trifluoromethyl)pyrimidin-2-yl]amino}phenyl)sulfoximide (BAY1000394) for the treatment of cancer

Lead optimization of a high-throughput screening hit led to the rapid identification of aminopyrimidine ZK304709, a multitargeted CDK and VEGF-R inhibitor that displayed a promising preclinical profile. Nevertheless, ZK304709 failed in phaseI studies due

SULFONE-SUBSTITUTED ANILINOPYRIMIDINE DERIVATIVES AS CDK INHIBITORS, THE PRODUCTION THEREOF, AND USE AS A MEDICINE

The invention relates to sulphone-substituted anilinopyrimidine derivatives of the formula (I), to its preparation processes, and to its use as medicament for treating various diseases.